ORIC Pharmaceuticals (ORIC) Stock Price, Quote, News & History | Benzinga

ORIC Pharmaceuticals Inc (ORIC) Stock Price, Quote, News & History

ORICNASDAQ

Trade with Public

Trade with Public

$13.13

0.241.86%

At close: Sep 2, 5:00 PM EST

$13.28

0.151.14%

After Hours: 5:52 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$12.97

Close

$13.13

Volume / Avg.

1.55M / 1.65M

Day Range

$12.83 - $13.53

52 Wk Range

7.23 - 14.93

Market Cap

$1.37B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

17.96%

Days to Cover

10.96

Recent ORIC Pharmaceuticals, Inc. News

Bandwidth, Traws Pharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Dow futures up 400 points; Bandwidth Inc (BAND) falls after $275M offering; other stocks declining in pre-market trading.

Avi Kapoor

What's Behind The Drop In Oric Pharmaceuticals Stock Today?

Shares of Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) are tumbling Wednesday after the company announced an update from the Phase 1b trial of rinzimetostat in combination with darolutamide in patients with metastatic castration-resistant prostate cancer.

Alex Perry

Beyond Meat Posts Downbeat Q4 Results, Joins RH, ORIC Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

US stock futures higher with Dow up 200 pts, Beyond Meat shares drop after downbeat results; ORIC, RH, Aptiv, Sweetgreen, Nike, and others also decline.

Avi Kapoor

Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Shares of nCino Inc (NASDAQ: NCNO) jumped 18% in pre-market trading after reporting strong Q4 results and issuing positive guidance for Q1 and FY27.

Avi Kapoor

ORIC Pharmaceuticals Stock Nosedives 25% After Hours: What Is Going On?

ORIC Pharmaceuticals stock rose after reporting positive cancer drug data and advancing to a Phase 3 trial, before falling sharply in after-hours trading.

Tanya Rawat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-111.64M

Investing Cash Flow (TTM)

-99.66M

Financing Cash Flow (TTM)

172.92M

Free Cash Flow (TTM)

-112.26M

Capital Expenditure (TTM)

-620.00K

Net Change in Cash (TTM)

-38.38M

Analyst Trends and Forecast

1

Mar

2

Apr

2

May

1

Jun

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.10B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.57

Earnings Yield % (TTM)

-9.90%

Earnings Yield % (FWD)

-14.09%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.68

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$37.48M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$12.97

Close

$13.13

Volume / Avg.

1.55M / 1.65M

Day Range

$12.83 - $13.53

52 Wk Range

7.23 - 14.93

Market Cap

$1.37B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

17.96%

Days to Cover

10.96

About

Sector

Health Care

Industry

Biotechnology

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision o...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy ORIC Pharmaceuticals (ORIC) stock?

A

You can purchase shares of ORIC Pharmaceuticals (NASDAQ:ORIC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ORIC Pharmaceuticals (ORIC) competitors?

A

Other companies in ORIC Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for ORIC Pharmaceuticals (ORIC) stock?

A

ORIC Pharmaceuticals has a consensus price target of $19.69.

Q

What is the current price for ORIC Pharmaceuticals (ORIC)?

A

The stock price for ORIC Pharmaceuticals (NASDAQ: ORIC) is $13.28 last updated September 2, 2026 at 5:52 PM EDT.

Q

Does ORIC Pharmaceuticals (ORIC) pay a dividend?

A

There are no upcoming dividends for ORIC Pharmaceuticals.

Q

When is ORIC Pharmaceuticals (NASDAQ:ORIC) reporting earnings?

A

ORIC Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is ORIC Pharmaceuticals (ORIC) going to split?

A

There is no upcoming split for ORIC Pharmaceuticals.

Q

What sector and industry does ORIC Pharmaceuticals (ORIC) operate in?

A

ORIC Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.